Listar por autor "Acebes Huerta, Andrea"

Analysis of clinical prognostic variables for Chronic Lymphocytic Leukemia decision-making problems

Andrés Galiana, Enrique Juan de

; Fernández Martínez, Juan Luis

; Luaces Rodríguez, Óscar

; Coz Velasco, Juan José del

; Huergo Zapico, Leticia

; Acebes Huerta, Andrea

; González Rodríguez, Segundo

; González Rodríguez, Ana Pilar

(Elsevier, 2016-04)

Caracterización Molecular del plasma rico en plaquetas (PRP) y secretomas de plaquetas. Asociación con la capacidad regenerativa in vitro

Acebes Huerta, Andrea

(Servicio de Publicaciones de la Universidad de Oviedo, 2024)

Characterization of the molecular composition and in vitro regenerative capacity of platelet-based bioproducts and related subfractions

Acebes Huerta, Andrea

; Martínez Botía, P.; Carbajo Argüelles, G.; Fernández Fuertes, Judit

; Muñoz Turrillas, M. C.; Ojea Pérez, A. M.; López Vázquez, A.; Eble, J. A.; Gutiérrez Gutiérrez, Laura

(2024)

Clinical Management of Hypertension, Inflammation and Thrombosis in Hospitalized COVID-19 Patients: Impact on Survival and Concerns

Martínez Botia, Patricia

; Bernardo, Ángel; Acebes Huerta, Andrea

; Caro, Alberto; Leoz, Blanca; Martínez Carballeira, Daniel; Palomo Antequera, Carmen

; Soto, Inmaculada; Gutiérrez Gutiérrez, Laura

(2021-03-04)

Clinical Response After Treatment of Knee Osteoarthritis With a Standardized, Closed-System, Low-Cost Platelet-Rich Plasma Product: 1-Year Outcomes

Fernández-Fuertes, Judit; Arias-Fernández, Tamara; Acebes Huerta, Andrea

; Álvarez-Rico, Marlene; Gutiérrez Gutiérrez, Laura

(2022-03-31)

Comparison of the PU.1 transcriptional regulome and interactome in human and mouse inflammatory dendritic cells

Scheenstra, Maaike R.; Martínez Botia, Patricia

; Acebes Huerta, Andrea

; Brouwer, Rutger W.W.; Caballero Sánchez, Noemí; Gillemans, Nynke; de Bleser, Pieter; Nota, Benjamin; De Cuyper, Iris M.; Salunkhe, Vishal; Woltman, Andrea M.; van de Laar, Lianne; Rijkers, Erikjan; Demmers, Jeroen A.A.; van IJcken, Wilfred F.J.; Philipsen, Sjaak; Van den Berg, Timo K.; Kuijpers, Taco W.; Gutiérrez Gutiérrez, Laura

(2020)

Desarrollo de estrategias de activación de la respuesta inmune antitumoral mediada por células NK

Acebes Huerta, Andrea

(2015-12)

Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors

Acebes Huerta, Andrea

; Lorenzo Herrero, Seila

; Rodríguez Folgueras, Alicia

; Huergo Zapico, Leticia

; López Larrea, Carlos

; López Soto, Alejandro

; González Rodríguez, Segundo

(2016)

Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia.Correlation with progressive disease

Huergo Zapico, Leticia

; Acebes Huerta, Andrea

; González Rodríguez, Ana Pilar

; Contesti, Juan Facundo

; González García, María Esther

; Payer, Ángel R.; Villa Álvarez, Mónica

; Fernández Guizán, Azahara

; López Soto, Alejandro

; González Rodríguez, Segundo

(2014)

Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA shedding

Huergo Zapico, Leticia

; González Rodríguez, Ana Pilar

; Contesti, Juan Facundo

; González García, María Esther

; López Soto, Alejandro

; Fernández Guizán, Azahara

; Acebes Huerta, Andrea

; Toyos González, Juan Ramón de los

; López Larrea, Carlos

; Groh, Veronika; Spies, Thomas; González Rodríguez, Segundo

(2012)

Immunophenotyping and cell sorting of human MKs from human primary sources or differentiated in vitro from hematopoietic progenitors

Acebes Huerta, Andrea

; Martínez Botia, Patricia

; Martín Martín, Cristina; Bernardo, Ángel; Rodríguez, Adrián R.; Vicente Ayuso, María Carmen; Benavente Cuesta, Celina; Gutiérrez Gutiérrez, Laura

(2021)

Implementation of a closed platelet-rich-plasma preparation method using the local blood bank infrastructure at the Principality of Asturias (Spain): Back to basic methodology and a demographics perspective after 1 year

Ojea Pérez, Ana María; Acebes Huerta, Andrea

; Arias Fernández, T.; Gutiérrez Gutiérrez, Laura

; Muñoz Turrillas, María Carmen (2019)

In vitro platelet production for transfusion purposes: Where are we now?

Martínez Botia, Patricia

; Acebes Huerta, Andrea

; Seghatchian, Jerard; Gutiérrez Gutiérrez, Laura

(2020)

Lenalidomide and Chronic Lymphocytic Leukemia

González Rodríguez, Ana Pilar

; Payer, Ángel R.; Acebes Huerta, Andrea

; Huergo Zapico, Leticia

; Villa Álvarez, Mónica

; González García, María Esther

; González Rodríguez, Segundo

(2013)

Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells

Acebes Huerta, Andrea

; Huergo Zapico, Leticia

; González Rodríguez, Ana Pilar

; Fernández Guizán, Azahara

; Payer, Ángel R.; López Soto, Alejandro

; González Rodríguez, Segundo

(Hindawi Publishing Corporation, 2014)

Method for obtaining a platelet derived secretome and uses thereof

Gutiérrez Gutiérrez, Laura

; Acebes Huerta, Andrea

(2023-03-02)

Modulación de la función plaquetaria con productos derivados de plaquetas

Miranda Sanz, Pelayo (2023-07-25)

Molecular bases for the regulation of NKG2D ligands in cancer

Huergo Zapico, Leticia

; Acebes Huerta, Andrea

; López Soto, Alejandro

; Villa Álvarez, Mónica

; González Rodríguez, Ana Pilar

; González Rodríguez, Segundo

(Frontiers, 2014)

NKG2D signaling in cancer immunosurveillance

López Soto, Alejandro

; Huergo Zapico, Leticia

; Acebes Huerta, Andrea

; Villa Álvarez, Mónica

; González Rodríguez, Segundo

(2014)

Novel insights into the use of platelet releasate as a therapeutic approach for tissue regeneration

Matsakas, Antonios; Scully, David; Sfyri, Peggy; Verpoorten, Sandrine; Wilkinson, Holly; Aburima, Ahmed; Gutiérrez Gutiérrez, Laura

; Acebes Huerta, Andrea

; Mitchell, Robert; Patel, Ketan; Hardman, Matthew (2019)

Listar por autor "Acebes Huerta, Andrea"

Analysis of clinical prognostic variables for Chronic Lymphocytic Leukemia decision-making problems ﻿

Caracterización Molecular del plasma rico en plaquetas (PRP) y secretomas de plaquetas. Asociación con la capacidad regenerativa in vitro ﻿

Characterization of the molecular composition and in vitro regenerative capacity of platelet-based bioproducts and related subfractions ﻿

Clinical Management of Hypertension, Inflammation and Thrombosis in Hospitalized COVID-19 Patients: Impact on Survival and Concerns ﻿

Clinical Response After Treatment of Knee Osteoarthritis With a Standardized, Closed-System, Low-Cost Platelet-Rich Plasma Product: 1-Year Outcomes ﻿

Comparison of the PU.1 transcriptional regulome and interactome in human and mouse inflammatory dendritic cells ﻿

Desarrollo de estrategias de activación de la respuesta inmune antitumoral mediada por células NK ﻿

Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors ﻿

Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia.Correlation with progressive disease ﻿

Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA shedding ﻿

Immunophenotyping and cell sorting of human MKs from human primary sources or differentiated in vitro from hematopoietic progenitors ﻿

Implementation of a closed platelet-rich-plasma preparation method using the local blood bank infrastructure at the Principality of Asturias (Spain): Back to basic methodology and a demographics perspective after 1 year ﻿

In vitro platelet production for transfusion purposes: Where are we now? ﻿

Lenalidomide and Chronic Lymphocytic Leukemia ﻿

Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells ﻿

Method for obtaining a platelet derived secretome and uses thereof ﻿

Modulación de la función plaquetaria con productos derivados de plaquetas ﻿

Molecular bases for the regulation of NKG2D ligands in cancer ﻿

NKG2D signaling in cancer immunosurveillance ﻿

Novel insights into the use of platelet releasate as a therapeutic approach for tissue regeneration ﻿

Analysis of clinical prognostic variables for Chronic Lymphocytic Leukemia decision-making problems

Caracterización Molecular del plasma rico en plaquetas (PRP) y secretomas de plaquetas. Asociación con la capacidad regenerativa in vitro

Characterization of the molecular composition and in vitro regenerative capacity of platelet-based bioproducts and related subfractions

Clinical Management of Hypertension, Inflammation and Thrombosis in Hospitalized COVID-19 Patients: Impact on Survival and Concerns

Clinical Response After Treatment of Knee Osteoarthritis With a Standardized, Closed-System, Low-Cost Platelet-Rich Plasma Product: 1-Year Outcomes

Comparison of the PU.1 transcriptional regulome and interactome in human and mouse inflammatory dendritic cells

Desarrollo de estrategias de activación de la respuesta inmune antitumoral mediada por células NK

Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors

Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia.Correlation with progressive disease

Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA shedding

Immunophenotyping and cell sorting of human MKs from human primary sources or differentiated in vitro from hematopoietic progenitors

Implementation of a closed platelet-rich-plasma preparation method using the local blood bank infrastructure at the Principality of Asturias (Spain): Back to basic methodology and a demographics perspective after 1 year

In vitro platelet production for transfusion purposes: Where are we now?

Lenalidomide and Chronic Lymphocytic Leukemia

Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells

Method for obtaining a platelet derived secretome and uses thereof

Modulación de la función plaquetaria con productos derivados de plaquetas

Molecular bases for the regulation of NKG2D ligands in cancer

NKG2D signaling in cancer immunosurveillance

Novel insights into the use of platelet releasate as a therapeutic approach for tissue regeneration